Christopher Nolan to reunite with Oppenheimer actor for new movie
Director Christopher Nolan is set to reunite with one of the stars from his multi-award-winning film Oppenheimer for his next movie. The Inception director will follow up his Oscar win with an adaptation of Homer’s The Odyssey, which is set to be released in July 2026.
Oppenheimer assumed coverage on shares of Alumis (NASDAQ:ALMS – Free Report) in a research note published on Thursday morning, MarketBeat.com reports. The firm issued an outperform rating and a $32.00 ...
(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...
British consumers’ appetite for home entertainment reached new heights in 2024, with the sector surpassing £5.1 billion ($6.4 ...
The card collecting industry has exploded in recent years to such an extent that industry leader Topps is now producing a Robert Oppenheimer card that's ...
Despite Christopher Nolan's "Oppenheimer" success, his upcoming adaptation of "The Odyssey" feels too ambitious to succeed.
cryptopolitan on MSN3d
Oppenheimer downgrades Apple, cites weakening iPhone sales and AI innovation worriesOppenheimer downgraded Apple from "outperform" to "perform" because it is struggling to adapt to a competitive AI landscape.
NEW YORK (AP) — NEW YORK (AP) — Oppenheimer Holdings Inc. (OPY) on Friday reported net income of $10.7 million in its fourth quarter. The company, based in New York, said it had earnings of 92 cents ...
Oppenheimer initiated coverage of Alumis (ALMS) with an Outperform rating and $32 price target The company is focused on delivering ...
Oppenheimer analysts maintained a Perform rating on ResMed (NYSE:RMD) following the company's financial results for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback